RITUXIMAB (ri TUX i mab) treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It may also be used to treat autoimmune conditions, such as arthritis. It works by slowing down an overactive immune system. It is a monoclonal antibody.
Learn More
Clinical Trials
Search Cancer Clinical Trials
Carefully controlled studies to research the safety and benefits of new drugs and therapies.